查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1467728

2024-2032 年按應用、配銷通路、給藥途徑和地區分類的人類生長激素市場報告

Human Growth Hormone Market Report by Application, Distribution Channel, Route of Administration, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年全球人類生長激素市場規模達57億美元。

HGH 是一種胜肽激素，由腦下垂體產生，可刺激兒童和成人的生長。此激素主要調節細胞的生長、再生、修復、繁殖和代謝，進而促進身體的整體發育。它還調節體液、脂肪代謝以及骨骼和肌肉的生長。 HGH 缺乏會增加疾病和脂肪堆積的風險，而較高水平會導致兒童巨人症和成人肢端肥大症、肌肉萎縮症和短腸症候群。

特納氏症和其他生長相關疾病的盛行率日益增加是推動市場成長的關鍵因素之一。特納氏症是一種主要影響女性的染色體疾病，其特徵是 X 染色體完全或部分缺失。生長激素通常用於逆轉這種疾病的一些症狀，從而增加了全球對 HGH 藥物的需求。此外，大眾健康意識的增強和對內分泌失調預防措施的認知不斷增強，也推動了市場的成長。普瑞德威利症候群 (PWS) 和特發性身材矮小 (ISS) 等多種疾病是由於體內生長激素缺乏引起的，而生長激素可以透過醫學合成的 HGH 進行治療。其他因素，包括健美運動員擴大使用 HGH 作為表現增強劑，以及重組人類生長激素 (rHGH) 的開發，預計將進一步推動市場發展。

本報告回答的關鍵問題

  • 全球人類生長激素市場有多大？
  • 2024-2032年全球人類生長激素市場的預期成長率是多少？
  • 推動全球人類生長激素市場的關鍵因素是什麼？
  • COVID-19 對全球人類生長激素市場有何影響？
  • 根據應用，全球人類生長激素市場的細分如何？
  • 根據配銷通路，全球人類生長激素市場的細分如何？
  • 根據給藥途徑，全球人類生長激素市場的細分如何？
  • 全球人類生長激素市場的關鍵區域有哪些？
  • 全球人類生長激素市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球人類生長激素市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按應用

  • 生長激素 (GH) 缺乏
    • 市場走向
    • 主要類型
      • 成人生長激素缺乏症
      • 兒童生長激素缺乏症
    • 市場預測
  • 特納氏症
    • 市場走向
    • 市場預測
  • 特發性身材矮小 (ISS)
    • 市場走向
    • 市場預測
  • 普瑞德威利症候群 (PWS)
    • 市場走向
    • 市場預測
  • 小於胎齡
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按配銷通路

  • 醫院藥房
    • 市場走向
    • 市場預測
  • 零售藥房
    • 市場走向
    • 市場預測
  • 網路藥房
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依管理途徑

  • 靜脈
    • 市場走向
    • 市場預測
  • 肌肉注射
    • 市場走向
    • 市場預測
  • 皮下
    • 市場走向
    • 市場預測
  • 口服
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太地區
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Eli Lilly and Company
    • EMD Serono Inc.
    • F. Hoffmann-La Roche AG
    • Ferring BV
    • Genentech Inc.
    • Ipsen
    • Merck KGaA
    • Novartis AG
    • Novo Nordisk
    • Pfizer Inc.
    • Sandoz
Product Code: SR112024A2052

The global human growth hormone market size reached US$ 5.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.9 Billion by 2032, exhibiting a growth rate (CAGR) of 7.2% during 2024-2032.

HGH is a peptide hormone that is produced by the pituitary gland to stimulate growth in children and adults. The hormone primarily regulates growth, regeneration, repair, reproduction and metabolism of the cells, thus contributing to the overall development of the body. It also regulates body fluids, fat metabolism and bone and muscle growth. The deficiency of HGH can increase the risk of diseases and fat accumulation, whereas higher levels can cause gigantism in children and acromegaly, muscle-wasting disease and short bowel syndrome in adults.

The increasing prevalence of Turner syndrome and other growth-related disorders is one of the key factors driving the growth of the market. Turner syndrome is a chromosomal disorder that primarily affects females and is characterized by complete or partial loss of X chromosomes. Growth hormones are often administered to reverse some of the symptoms of this disease, thereby increasing the demand for HGH drugs across the globe. Furthermore, increasing health consciousness among the masses and growing awareness regarding the preventive measures against endocrine disorders, are providing a boost to the market growth. Various disorders, such as Prader-Willi syndrome (PWS) and idiopathic short stature (ISS), are caused by the deficiency of growth hormones in the body that can be treated using medically synthesized HGH. Other factors, including a rising utilization of HGH as performance enhancers by bodybuilders, along with the development of recombinant human growth hormone (rHGH), are projected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global human growth hormone market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on application, distribution channel and route of administration.

Breakup by Application:

Growth Hormone (GH) Deficiency

Adult GH Deficiency

Pediatric GH Deficiency

Turner Syndrome

Idiopathic Short Stature (ISS)

Prader-Willi Syndrome (PWS)

Small for Gestational Age

Others

Breakup by Distribution Channel:

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy

Others

Breakup by Route of Administration:

Intravenous

Intramuscular

Subcutaneous

Oral

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Eli Lilly and Company, EMD Serono Inc., F. Hoffmann-La Roche AG, Ferring B.V., Genentech Inc., Ipsen, Merck KGaA, Novartis AG, Novo Nordisk, Pfizer Inc., Sandoz, etc.

Key Questions Answered in This Report

  • 1. How big is the global human growth hormone market?
  • 2. What is the expected growth rate of the global human growth hormone market during 2024-2032?
  • 3. What are the key factors driving the global human growth hormone market?
  • 4. What has been the impact of COVID-19 on the global human growth hormone market?
  • 5. What is the breakup of the global human growth hormone market based on the application?
  • 6. What is the breakup of the global human growth hormone market based on the distribution channel?
  • 7. What is the breakup of the global human growth hormone market based on the route of administration?
  • 8. What are the key regions in the global human growth hormone market?
  • 9. Who are the key players/companies in the global human growth hormone market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Human Growth Hormone Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Application

  • 6.1 Growth Hormone (GH) Deficiency
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Adult GH Deficiency
      • 6.1.2.2 Pediatric GH Deficiency
    • 6.1.3 Market Forecast
  • 6.2 Turner Syndrome
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Idiopathic Short Stature (ISS)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Prader-Willi Syndrome (PWS)
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Small for Gestational Age
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Pharmacy
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Intravenous
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Intramuscular
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Subcutaneous
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Oral
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Eli Lilly and Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 EMD Serono Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 F. Hoffmann-La Roche AG
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 SWOT Analysis
    • 13.3.4 Ferring B.V.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
    • 13.3.5 Genentech Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 SWOT Analysis
    • 13.3.6 Ipsen
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Merck KGaA
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
    • 13.3.8 Novartis AG
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Novo Nordisk
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Pfizer Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Sandoz
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Human Growth Hormone Market: Major Drivers and Challenges
  • Figure 2: Global: Human Growth Hormone Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Human Growth Hormone Market: Breakup by Application (in %), 2023
  • Figure 4: Global: Human Growth Hormone Market: Breakup by Distribution Channel (in %), 2023
  • Figure 5: Global: Human Growth Hormone Market: Breakup by Route of Administration (in %), 2023
  • Figure 6: Global: Human Growth Hormone Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Human Growth Hormone Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 8: Global: Human Growth Hormone (Growth Hormone Deficiency) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Human Growth Hormone (Growth Hormone Deficiency) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Human Growth Hormone (Turner Syndrome) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Human Growth Hormone (Turner Syndrome) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Human Growth Hormone (Idiopathic Short Stature- ISS) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Human Growth Hormone (Idiopathic Short Stature- ISS) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Human Growth Hormone (Prader-Willi Syndrome- PWS) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Human Growth Hormone (Prader-Willi Syndrome- PWS) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Human Growth Hormone (Small for Gestational Age) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Human Growth Hormone (Small for Gestational Age) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Human Growth Hormone (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Human Growth Hormone (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Human Growth Hormone (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Human Growth Hormone (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Human Growth Hormone (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Human Growth Hormone (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Human Growth Hormone (Online Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Human Growth Hormone (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Human Growth Hormone (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Human Growth Hormone (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Human Growth Hormone (Intravenous) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Human Growth Hormone (Intravenous) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Human Growth Hormone (Intramuscular) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Human Growth Hormone (Intramuscular) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Human Growth Hormone (Subcutaneous) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Human Growth Hormone (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Human Growth Hormone (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Human Growth Hormone (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: North America: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: North America: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: United States: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: United States: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Canada: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Canada: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Asia Pacific: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Asia Pacific: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: China: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: China: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Japan: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Japan: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: India: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: India: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: South Korea: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: South Korea: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Australia: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Australia: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Indonesia: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Indonesia: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Others: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Others: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Europe: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Europe: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Germany: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Germany: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: France: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: France: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: United Kingdom: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: United Kingdom: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Italy: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Italy: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Spain: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Spain: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Russia: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Russia: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Latin America: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Latin America: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Brazil: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Brazil: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Mexico: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Mexico: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Others: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Others: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Middle East and Africa: Human Growth Hormone Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Middle East and Africa: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Global: Human Growth Hormone Industry: SWOT Analysis
  • Figure 85: Global: Human Growth Hormone Industry: Value Chain Analysis
  • Figure 86: Global: Human Growth Hormone Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Human Growth Hormone Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Human Growth Hormone Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 3: Global: Human Growth Hormone Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 4: Global: Human Growth Hormone Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 5: Global: Human Growth Hormone Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Human Growth Hormone Market: Competitive Structure
  • Table 7: Global: Human Growth Hormone Market: Key Players